Akt (pan) (C67E7) Rabbit Monoclonal Anti… and 1 more item

The University of Nebraska Medical Center (UNMC), located in Omaha, Nebraska, awarded a purchase order (PO) to Cell Signaling Technology Inc., a Boston-based vendor, for two specific research-grade monoclonal antibodies. The contract, numbered 4800164383, was issued on December 9, 2025, with a total contract value of $678.00. The order consists of two line items: an Akt (pan) (C67E7) Rabbit Monoclonal Anti-antibody and a Stat1 (D4Y6Z) Rabbit Monoclonal Antibody, each priced at $339.00.

The purchase order specifies delivery to UNMC Shipping and Receiving at 601 S Saddle Creek Rd, Omaha, NE 68106, with a specific unloading point of BCC 8.12.384 AAT Hollings. The contract's performance period is brief, running from the award date of December 9, 2025, to the completion date of December 16, 2025. Payment terms are set at Net 30, and the purchase is governed by the University of Nebraska's Standard Terms of Purchase. The transaction is tax-exempt under ID 05-8905401, with each antibody to be delivered in a quantity of one unit.